HERON THERAPEUTICS, INC. /DE/ (HRTX) Gross profit 2016–2025
HERON THERAPEUTICS, INC. /DE/ (HRTX) annual gross profit history from SEC filings — each fiscal year as reported.
$113.6MFY2025 · since FY2016: $1.2M → $113.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $113.6M | +7.5% |
| FY2024 | $105.6M | +70.6% |
| FY2023 | $61.9M | +17.3% |
| FY2022 | $52.8M | +30.9% |
| FY2021 | $40.3M | -23.1% |
| FY2020 | $52.4M | -37.8% |
| FY2019 | $84.3M | +68.8% |
| FY2018 | $50.0M | +90.8% |
| FY2017 | $26.2M | +2004.4% |
| FY2016 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HRTX financial trends
HRTX RevenueHRTX Net incomeHRTX Net marginHRTX Gross marginHRTX Operating incomeHRTX Operating marginHRTX Operating cash flowHRTX Free cash flowHRTX Capital expendituresHRTX Return on equityHRTX Stock buybacksHRTX Dividends paidHRTX Total assetsHRTX Total liabilitiesHRTX Shareholders’ equityHRTX overview →